Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma. (Q39133831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Katarina Riesner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Nils C Lehnen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Anne von Mässenhausen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Holger Kalthoff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hui Zhou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ute Schütte

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Tobias Höller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Diana Boehm

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jutta Kirfel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sven Perner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ines Gütgemann

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sabine Merkelbach-Bruse

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

28 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

157-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

4 March 2020

cites work

1 reference

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database

21 January 2018

1 reference

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

21 January 2018

1 reference

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer

21 January 2018

1 reference

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

21 January 2018

1 reference

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer

21 January 2018

1 reference

Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.

21 January 2018

1 reference

Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).

21 January 2018

1 reference

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

21 January 2018

1 reference

Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

21 January 2018

1 reference

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.

21 January 2018

1 reference

Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase

21 January 2018

1 reference

High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues

21 January 2018

1 reference

IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells

21 January 2018

1 reference

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

21 January 2018

1 reference

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway

21 January 2018

1 reference

A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

21 January 2018

1 reference

Cellular signaling by fibroblast growth factor receptors

21 January 2018

1 reference

FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor.

21 January 2018

1 reference

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

21 January 2018

1 reference

Advanced or metastatic pancreatic cancer: molecular targeted therapies

21 January 2018

1 reference

Molecular targeted therapies for pancreatic cancer

21 January 2018

1 reference

FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23808822%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference